Health Economic Assessment of Tygacil® in the Treatment of Secondary Peritonitis in Intensive Care Units (ICUs)

NCT00481962 · clinicaltrials.gov ↗

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Peritonitis

Interventions

DRUG: Tygacil

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer